Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Other Non-Current Liabilities (2022 - 2025)

HCW Biologics (HCWB) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $692531.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $692531.0, compared with a TTM value of $692531.0 through Sep 2025, changed N/A, and an annual FY2023 reading of $68500.0, up 379.86% over the prior year.
  • Other Non-Current Liabilities was $692531.0 for Q3 2025 at HCW Biologics, down from $1.7 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.7 million in Q2 2025 and bottomed at $7476.0 in Q1 2023.
  • Average Other Non-Current Liabilities over 3 years is $314611.3, with a median of $68500.0 recorded in 2023.
  • Peak annual rise in Other Non-Current Liabilities hit 379.86% in 2023, while the deepest fall reached 94.64% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $14275.0 in 2022, then surged by 379.86% to $68500.0 in 2023, then surged by 910.99% to $692531.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for HCWB at $692531.0 in Q3 2025, $1.7 million in Q2 2025, and $54000.0 in Q1 2025.